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Background: Nephrotoxicity is a common side effect of medications. Panax ginseng is one of the best-
known herbal medicines, and its individual constituents enhance renal function. Identiﬁcation of its
efﬁcacy and mechanisms of action against drug-induced nephrotoxicity, as well as the speciﬁc constit-
uents mediating this effect, have recently emerged as an interesting research area focusing on the kidney
protective efﬁcacy of P. ginseng.
Methods: The present study investigated the kidney protective effect of fermented black ginseng (FBG)
and its active component ginsenoside 20(S)-Rg3 against cisplatin (chemotherapy drug)-induced damage
in pig kidney (LLC-PK1) cells. It focused on assessing the role of mitogen-activated protein kinases as
important mechanistic elements in kidney protection.
Results: The reduced cell viability induced by cisplatin was signiﬁcantly recovered with FBG extract and
ginsenoside 20(S)-Rg3 dose-dependently. The cisplatin-induced elevated protein levels of phosphory-
lated c-Jun N-terminal kinase (JNK), p53, and cleaved caspase-3 were decreased after cotreatment with
FBG extract or ginsenoside 20(S)-Rg3. The elevated percentage of apoptotic LLC-PK1 cells induced by
cisplatin treatment was signiﬁcantly abrogated by cotreatment with FBG and the ginsenoside 20(S)-Rg3.
Conclusion: FBG and its major ginsenoside 20(S)-Rg3, ameliorated cisplatin-induced nephrotoxicity in
LLC-PK1 cells by blocking the JNKep53ecaspase-3 signaling cascade.
Copyright 2015, The Korean Society of Ginseng, Published by Elsevier. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Panax ginseng is one of the best-known herbal medicines and its
individual constituents enhance renal function [1]. P. ginseng
effectively ameliorated renal dysfunction induced by streptozotocin
in rats by attenuating oxidative stress [2]. Korean Red Ginseng not
only inhibited the formation of advanced glycation end productse, Gachon University, 1342 Seongn
iversity of Ulsan College of Medic
, jhj@gnah.co.kr (H.-J. Jang).
scribed in this study.
ht 2015, The Korean Society of Gi
d/4.0/).and expression of tumor necrosis factor (TNF)-a, but also blocked
the mitogen-activated protein kinases (MAPKs) and nuclear factor
kappa-light-chain-enhancer of activated B cell-mediated inﬂam-
matory pathways in streptozotocin-induced diabetic renal damage
[3].
Nephrotoxicity is a common side effect of medications and ac-
counts for approximately 20% of hospital admissions for acuteamDaero, Sujeong-Gu, Seongnam 461-701, Korea.
ine, 38 Bangdong gil, Sachean Myeon, Gangneung 210-711, Korea.
nseng, Published by Elsevier. This is an open access article under the CC BY-NC-ND
J Ginseng Res 2016;40:135e140136kidney injury [4]. Toxic effects on the kidney related to medications
are common and may present as a subtle injury or overt renal
failure [5]. Therefore, evaluation of the efﬁcacy of P. ginseng in drug-
induced nephrotoxicity, as well as the mechanisms and active
constituents involved in this action, have recently emerged as an
interesting area of ginseng research focused on its potential efﬁcacy
for kidney protection [6].
P. ginseng prevented renal impairment induced by gentamicin,
an aminoglycoside antibiotic, in rats [1]. Gentamicin-induced
nephrotoxicity is related to oxidative damage. Coadministration
with P. ginseng decreased the renal damage induced by gentamicin
via the inhibition of free radical formation and restoration of the
antioxidant systems [7,8]. Among the several constituents of
ginseng, phenolic acids and ﬂavonoids, which are responsible for
the increase in renal blood ﬂow and elimination of free radicals,
exhibited protective effects against gentamicin-induced oxidative
nephrotoxicity [9].
Cyclosporine, an immunosuppressant drug causes impairment,
typical pathologic lesions, and apoptotic cell death in the kidneys
[10]. Ginseng protects against cyclosporine-induced renal injury by
decreasing the induction of excessive autophagosomes and protein
aggregates [11]. Korean Red Ginseng also exhibited protective ef-
fects in cyclosporine-induced renal injury via the reduction of renal
dysfunction, oxidative stress, and proinﬂammatory molecules such
as induced nitric oxide synthase, cytokines, and transforming
growth factor-b1 in rats [10].
Ginsenosides, which are 30-carbon glycosides derived from the
triterpenoid dammarane, aremajor active constituents of P. ginseng.
Ginsenosides inhibited the cantharidin-induced cytotoxicity in
normal rat kidney cells. Pretreatment with ginsenosides reduced
the increases in serum creatinine, urine protein, blood urea nitro-
gen, and histological changes in rats [12]. These ﬁndingsmay reﬂect
the improvements of renal dysfunction by certain ginsenosides in
drug-induced nephrotoxicity.
Research has been conducted to develop methods for increasing
the pharmacological efﬁcacy of ginseng by converting the
dammarane-based saponins using thermal processing [13]. In line
with this notion, black ginseng has been prepared by heat pro-
cessing and fermentation of raw ginseng. Although some studies of
ginseng have focused on its renoprotective effects in diabetes [3],
little is known about the effects of black ginseng against nephro-
toxicity induced by medications.
The present study sought to investigate the renoprotective ef-
fect of black ginseng and its active component ginsenoside 20(S)-
Rg3, against cisplatin (a chemotherapy drug)-induced damage in
pig kidney (LLC-PK1) cells. In addition, we focused on assessing the
role of MAPKs as important mechanistic elements in the kidney
protective effects of black ginseng.
2. Materials and methods
2.1. Chemicals and reagents
Ginsenoside 20(S)-Rg3 was purchased from the Ambo Institute
(Dajeon, Korea). Cisplatin was purchased from Sigma Aldrich
(Seoul, Korea). Dulbecco’s modiﬁed Eagle’s medium was obtained
from Cellgro (Manassas, VA, USA). Fetal bovine serum was
purchased from Invitrogen Co. (Grand Island, NY, USA). The anti-
bodies for p38 MAPK, phospho-p38, p44/42 MAPK-extracellular
signal-regulated kinases, phospho-p44/42, c-Jun-N-terminal ki-
nase (JNK), phospho-JNK, p53, cleaved caspase-3, glyceraldehyde
3-phosphate dehydrogenase (GAPDH), and the horseradish
peroxidase-conjugated antirabbit antibodies were procured from
Cell Signaling (Boston, MA, USA). Other chemicals and reagents
were of high quality and obtained from commercial sources.2.2. Preparation of ginseng extracts
Dried powder extract of black ginseng was supplied by the
Ginseng By Pharm Co., Ltd., (Wonju, Korea). Four-year-old white
ginseng was purchased from a local ginseng market (Geumsan,
Korea). The authenticity of the ginseng was determined based on
the ingredient proﬁle. The black ginseng was prepared by nine
cycles of repeated steaming of thewhite ginseng at 85C for 8 h and
drying at 50C for 48 h. To prepare the ginseng extracts, black
ginseng was crushed into a powder and extracted once with 10
volumes of distilled water at 80C for 72 h, and then ﬁltered and
chilled. The ginseng extract was fermented with Saccharomyces
cerevisiae (Lallemand, Grenaa, Denmark) at 34C for 25 h. Following
fermentation, the black ginseng extract was sterilized at 85C for
22 h, and then lyophilized. The ginsenosides present in the black
ginseng extracts used in this study were Rg2, Rg3, Rh1, Rh2, and Rf
at a content of 2.86 mg/mL, 24.52 mg/mL, 12.62 mg/mL, 0.63 mg/mL,
and 1.32 mg/mL, respectively [14].
2.3. Renoprotective effect against cisplatin-induced damage in
kidney cells
The protective effect against oxidative renal cell damage was
evaluated using LLC-PK1 cells [15]. The LLC-PK1 cells were pur-
chased from the American Type Culture Collection (ATCC, Rock-
ville, MD, USA) and cultured in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% fetal bovine serum, 1% peni-
cillin/streptomycin, and 4mM L-glutamine at 37C in an atmo-
sphere of 5% CO2. The cells were seeded in 96-well culture plates
at 1  104 cells/well and allowed to adhere for 2 h. Then, the test
sample, radical donor 25mM cisplatin, or both were added to the
culture medium. Following a 24-h incubation, the medium con-
taining the test sample, radical donor, or both was removed. The
cells were incubated in serum-free medium (90 mL/well) and Ez-
Cytox reagent (10 mL/well, Itsbio, Seoul, Korea) at 37C for 2 h. The
cell viability was determined by measuring the absorbance at
450 nm using a microplate reader (PowerWave XS; BioTek In-
struments, Winooski, VT, USA).
2.4. Western blot analysis
Whole-cell extracts were prepared according to the manufac-
turer’s instructions using a radioimmunoprecipitation assay buffer
(Cell Signaling, Danvers, MA, USA) supplemented with 1mM phe-
nylmethylsulfonyl ﬂuoride. The proteins (whole-cell extracts,
20 mg/lane) were separated using electrophoresis in a precast 4e
15% Mini-PROTEAN TGX gel (Bio-Rad, Hercules, CA, USA) blotted
onto polyvinylidene ﬂuoride (PVDF) membranes and analyzed us-
ing epitope-speciﬁc primary and secondary antibodies [16]. The
bound antibodies were visualized using an enhanced chem-
iluminescence advance western blotting detection reagents (GE
Healthcare, Buckinghamshire, UK) and a Fusion Solo chem-
iluminescence system (Peqlab Biotechnologie GmbH, Erlangen,
Germany).
2.5. Image-based cytometric assay
LLC-PK1 cells were used for an image-based apoptosis assay
system. All assays were conducted in accordance with the guide-
lines for operating the Tali image-based cytometer (Invitrogen,
Carlsbad, CA, USA). The cells were treated with samples for 24 h at
37C under 5 % CO2. The cells were harvested by trypsin treatment
using the TrypLE reagent and stained using the Tali apoptosis kit
(Invitrogen). The sample was divided and analyzed independently
using both the Tali image and ﬂow cytometers following the
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the cell population was determined by staining with annexin V-
Alexa Fluor 488 conjugate. Propidium iodide (PI) was used to
differentiate the dead cells (annexin V positive/PI positive or
annexin V negative/PI positive) from the apoptotic cells (annexin V
positive/PI negative). The percentages of the cell population re-
ported as viable, apoptotic, and dead by the Tali cytometer were
comparable with the data from the same samples independently
run on the ﬂow cytometer [17].2.6. Statistical analysis
Statistical signiﬁcance was determined using an analysis of
variance followed by a multiple comparison test with a Bonferroni
adjustment. A p value < 0.05 was considered statisticallyFig. 1. The protective effects of black ginseng and ginsenoside 20(S)-Rg3 on cisplatin-induced
black ginseng and ginsenoside 20(S)-Rg3 following treatment with 25 mM cisplatin. (B) Prote
PK1 cells. LLC-PK1 cells were pretreated with various concentrations of black ginseng and g
Cell viability was assessed using the MTT assay. *p < 0.05 compared with the cisplatin-
diphenyltetrazolium bromide.signiﬁcant. The analysis was performed using the statistics for the
social sciences (SPSS) version 19.0 (SPSS Inc., Chicago, Il, USA).
3. Results and discussion
Cisplatin is one of the most effective and widely used anticancer
drugs for the treatment of various solid tumors; however, it causes
nephrotoxicity, one of the most well-known and clinically impor-
tant side-effects [18,19]. Earlier studies demonstrated that several
mechanisms including oxidative stress, DNA damage, and inﬂam-
matory responses are closely associated with cisplatin-induced
nephrotoxicity [19,20]. Cisplatin is known to activate p38, extra-
cellular signal-regulated kinases (ERK), and JNK/stress-activated
protein kinases in the kidneys both in vitro and in vivo [21]. In
addition, genomic DNA is presumably a primary target of cisplatin
in tubular cells. The tumor suppressor gene p53 is induced inrenal cell damage. (A) Representative microscopic image of nephroprotective effects of
ction assay of black ginseng and ginsenoside 20(S)-Rg3 in cisplatin-treated (25 mM) LLC-
insenoside 20(S)-Rg3 for 2 h, and then further treated with 25 mM of cisplatin for 24 h.
treated group. FBG, fermented black ginseng; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-
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repair and cell death by apoptosis [22,23]. In the present study, we
sought to identify the kidney protective effect of black ginseng
extract and its active ginsenoside 20(S)-Rg3, as well as the mech-
anisms involved, to determine its therapeutic potential.
We carried out a cell-based kidney protection assay to evaluate
the protective effects of black ginseng extract and ginsenoside
20(S)-Rg3 on LLC-PK1 cells. The kidney cell protection assay con-
dition was established using the LLC-PK1 cell line, which is
commonly used in the evaluation of nephrotoxicity [24,25]. The
viability of the LLC-PK1 cells reduced to 60% of the control cell
viability after treatment with 25mM of cisplatin. The reduced cell
viability induced by cisplatin was signiﬁcantly recovered by black
ginseng and ginsenoside 20(S)-Rg3 dose-dependently (Fig. 1). The
black ginseng extract and ginsenoside 20(S)-Rg3 ameliorated the
cisplatin-induced nephrotoxicity to control levels at concentrations
of 500 mg/mL and 250 mg/mL, respectively.Fig. 2. The c-Jun N-terminal kinase (JNK)ep53ecaspase-3 signaling pathway mediates th
cultured LLC-PK1 cells. (A) Results of the Western blot analysis show the levels of phospho
black ginseng and ginsenoside 20(S)-Rg3 with or without cisplatin at different concentratio
blot analysis. Whole cell lysates (20 mg)were separated using sodium dodecyl sulfate polya
with the indicated antibodies. Proteins were visualized using an enhanced chemilumines
extracellular signal-regulated kinases; FBG,fermented black ginseng; GAPDH, glyceraldehydDysregulation of normal MAPK signaling has been implicated in
both acute and chronic kidney disease [26]. In the present study, we
sought to determine the role of theMAPKsep53ecaspase apoptotic
cascade in mediating the protective effects of black ginseng and
ginsenoside 20(S)-Rg3 against oxidative cytotoxicity in renal cells.
As shown in Fig. 2, the phosphorylation of JNK was observed 24 h
after cisplatin treatment and decreased following treatment with
black ginseng and ginsenoside 20(S)-Rg3. However, there were no
signiﬁcant changes in p-ERK and p-p38 (data not shown).
Cisplatin-induced nephrotoxicity is dependent on DNA damage-
induced apoptosis [27]. The protein level of p53, which was also
markedly increased after treatment with cisplatin, was reduced
signiﬁcantly by a high concentration of black ginseng and ginse-
noside 20(S)-Rg3. Similarly, the elevated levels of cleaved caspase-3
also decreased after treatment with black ginseng and ginsenoside
20(S)-Rg3. Fig. 3 shows the effects of black ginseng extract and
ginsenoside 20(S)-Rg3 on apoptosis in LLC-PK1 cells. As shown ine protective effect of black ginseng and ginsenoside 20(S)-Rg3 against cytotoxicity in
rylated (p)-JNK, JNK, p53, cleaved caspase-3, and GAPDH in LLC-PK1 cells treated with
ns for 24 h. (B) Quantitative results for p-JNK, p53 and cleaved caspase-3 from Western
crylamide gel electrophoresis, transferred onto PVDF transfer membranes, and probed
cence detection system. *p < 0.05 compared with the cisplatin-treated group. ERK,
e 3-phosphate dehydrogenase.
Fig. 3. Effects of black ginseng and ginsenoside 20(S)-Rg3 on apoptosis in LLC-PK1 cells. (A) Representative images of apoptosis detection. (B) Percentage of annexin V-positive-
stained apoptotic cells. Dead and apoptotic cells were stained with red and green ﬂuorescence. Apoptosis was determined using a Tali image-based cytometer. *p < 0.05 compared
with the cisplatin-treated group. FBG, fermented black ginseng.
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with red and green ﬂuorescence and increased after cisplatin
treatment, decreased following cotreatment with black ginseng
and more signiﬁcantly with ginsenoside 20(S)-Rg3. The elevated
percentage of apoptotic LLC-PK1 cells induced by cisplatin treat-
ment was markedly decreased following the cotreatment with
black ginseng and ginsenoside 20(S)-Rg3 (Fig. 3B).
Cisplatin-induced kidney damage has been correlated with the
formation of free radicals and oxidative stress, which can activate
MAPKs [24,28,29]. Treatment with antioxidants and caspase in-
hibitors can alleviate the effects of cisplatin-related nephrotoxicity.
There is considerable evidence showing that the MAPKs, p53, and
caspase pathways play important roles in regulation of theapoptosis pathways, as well as the inﬂammatory process [23,30].
The present results show that the JNKep53ecaspase-3 signaling
cascade plays a critical role in mediating the protective effects of
black ginseng and ginsenoside 20(S)-Rg3 against oxidative cyto-
toxicity in cultured LLC-PK1 cells.
Ginseng showed protective effects against cisplatin-induced
nephrotoxicity by alleviating the decreased activities of antioxi-
dant enzymes including superoxide dismutase, glutathione
peroxidase, catalase, and glutathione S-transferase as well as the
levels of glutathione. This effect consequently reduced the oxida-
tive stress, alterations in biochemical parameters, histological
changes, genomic DNA damage, as well as the expression of TNF-a,
interleukin-6, and the tumor suppressor p53 [31]. Pretreatment
J Ginseng Res 2016;40:135e140140with ginsenoside F11 reduced cisplatin-induced elevation of blood
urea nitrogen and creatinine levels, as well as ameliorated the
histopathological damage. Further studies showed that F11 sup-
pressed p53 activation, inversed the ratio of B-cell lymphoma-2
associated X protein/B-cell lymphoma-2, and the antioxidative
and free radical levels induced by cisplatin, which in turn inhibited
tubular cell apoptosis [32]. However, the effect and mechanism of
action of ginsenoside 20(S)-Rg3 have not been identiﬁed so far.
In conclusion, our results suggest that black ginseng ameliorates
nephrotoxicity in LLC-PK1 cells, and ginsenoside 20(S)-Rg3 is likely
the major component that mediates this effect through blockade of
the JNKep53ecaspase-3 signaling cascade.
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